Equimedical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 07-12-2024
- Paid Up Capital ₹ 0.38 M
as on 07-12-2024
- Company Age 3 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 59264.19%
(FY 2023)
- Profit -1079.15%
(FY 2023)
- Ebitda -1063.87%
(FY 2023)
- Net Worth -1198.28%
(FY 2023)
- Total Assets -4383.70%
(FY 2023)
About Equimedical
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.38 M, as per Ministry of Corporate Affairs (MCA) records.
Radhakrishnan Anoop and Raunak Singhvi serve as directors at the Company.
- CIN/LLPIN
U33209KA2021PTC155231
- Company No.
155231
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Equimedical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raunak Singhvi  | Additional Director | 08-Feb-2022 | Current |
| Radhakrishnan Anoop | Director | 06-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Equimedical.
Equimedical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59264.19% increase. The company also saw a substantial fall in profitability, with a 1079.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1198.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Equimedical?
Unlock access to Equimedical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Addresshealth Solutions India Private LimitedActive 14 years 8 monthsRadhakrishnan Anoop is a mutual person
Indian School Finance Company Private LimitedActive 30 years 7 monthsRaunak Singhvi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Equimedical?
Equimedical has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Equimedical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Equimedical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
